Timing of Confirmatory Trials for Drugs Granted Accelerated Approval Based on Surrogate Measures From 2012 to 2021

JAMA Health Forum. 2023 Mar 3;4(3):e230217. doi: 10.1001/jamahealthforum.2023.0217.
No abstract available

Plain language summary

This cross-sectional study systematically characterizes the frequency of delayed confirmatory trials relative to deadlines set by the US Food and Drug Administration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents*
  • Drug Approval

Substances

  • Antineoplastic Agents